23.05.2013 • News

Forest Labs' Longtime CEO Solomon to Step Down at Year-end

Forest Laboratories said on Thursday that Howard Solomon, who has led the biotech firm since 1977, will retire as chief executive officer at the end of this year and the company will name a successor by that time.

The company said it has been evaluating internal and external candidates.

Solomon, who is turning 86 in August, will continue in the chairman role until the annual shareholder meeting in 2014. He will stand for re-election to the board of directors at that time and become chairman emeritus.

Forest Labs adopted a shareholder rights plan last year after investor Carl Icahn built up a more than 10% stake in the company. In August of 2012 he won one of four board seats that he sought at the company after a bitter proxy fight.

 

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.